Misonix to Participate in Three Upcoming Investor Conferences
November 08 2018 - 08:30AM
Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a
provider of minimally invasive therapeutic ultrasonic medical
devices that enhance clinical outcomes, today announced that
management will be participating in three upcoming investor
conferences:
- Craig-Hallum Alpha Select Conference
- Date: Thursday, November 15, 2018
- Location: Sheraton New York Times Square Hotel, New York,
N.Y.
- Canaccord Genuity Medical Technologies &
Diagnostics Forum
- Date: Thursday, November 15, 2018
- Location: Westin Grand Central Hotel, New York,
N.Y.
- Piper Jaffray 30th Annual Healthcare
Conference
- Date: Wednesday, November 28, 2018
- Location: Lotte New York Palace Hotel, New York, N.Y.
Misonix President and Chief Executive Officer,
Stavros Vizirgianakis, along with Joe Dwyer, Misonix Chief
Financial Officer, will be available to meet with institutional
investors in one-on-one meetings throughout the day.
The Misonix investor presentation is available
in the “Investor Relations” section of the Company’s website at
www.misonix.com. If you have questions about Misonix or are
interested in conducting a conference call or meeting with
management, please contact the Company’s investor relations firm,
JCIR, at (212) 835-8500 or via email at mson@jcir.com.
About Misonix, Inc.Misonix,
Inc. (NASDAQ: MSON) designs, manufactures and markets ultrasonic
medical devices for the precise removal of hard and soft tissue,
including bone removal, wound debridement and ultrasonic
aspiration. Misonix is focused on leveraging its proprietary
ultrasonic technology to become the standard of care in operating
rooms and clinics around the world. Misonix's proprietary
ultrasonic medical devices are used in a growing number of medical
procedures, including spine surgery, neurosurgery, orthopedic
surgery, cosmetic surgery, laparoscopic surgery, and other surgical
and medical applications. At Misonix, Better Matters to us. That is
why throughout the Company’s history, Misonix has maintained its
commitment to medical technology innovation and the development of
ultrasonic surgical products that radically improve patient
outcomes. Additional information is available on the Company's web
site at www.misonix.com.
|
|
|
Contact: |
|
|
Joe Dwyer |
|
Joseph Jaffoni,
Norberto Aja, Jennifer Neuman |
Chief Financial
Officer |
|
JCIR |
Misonix, Inc. |
|
212-835-8500 or
mson@jcir.com |
631-927-9113 |
|
|
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Feb 2024 to Mar 2024
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Mar 2023 to Mar 2024